首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備

自動注射器市場規模、佔有率和成長分析：按應用、技術、給藥途徑、治療領域、銷售、最終用戶和地區分類 - 產業預測，2026-2033年

市場調查報告書

商品編碼

2064822

自動注射器市場規模、佔有率和成長分析：按應用、技術、給藥途徑、治療領域、銷售、最終用戶和地區分類 - 產業預測，2026-2033年

Auto Injector Market Size, Share, and Growth Analysis, By Usage (Disposable, Reusable), By Technology (Manual, Automatic), By Route of Administration, By Therapy Area, By Volume, By End User, By Region - Industry Forecast 2026-2033

出版日期: 2026年06月09日 | 出版商:

SkyQuest | 英文 194 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024 年全球自動注射器市場價值為 95.8 億美元，預計到 2033 年將成長至 322 億美元，而 2025 年為 109.6 億美元，預測期（2026-2033 年）的複合年成長率為 14.42%。

在多種醫療、技術和行為因素的推動下，自動注射器市場正經歷顯著成長，這些因素正在重塑藥物輸送方式。隨著慢性病盛行率的不斷上升，定期注射藥物的需求日益成長，而自動注射器提供了一種極具吸引力的解決方案，患者只需接受極少的培訓即可自行注射。這減少了就醫次數，提高了治療順從性。自動注射器的便利性對於應對緊急醫療狀況（例如嚴重過敏反應）尤其重要。技術創新已將這些設備轉變為使用者友善智慧工具，具備自動化功能和劑量追蹤連接能力。生物製藥的興起以及患者對居家醫療期望的不斷提高進一步推動了市場需求。此外，人工智慧的整合正在提升個人化治療和用藥依從性，從而實現最佳化治療方案和及時調整用藥。

自動注射器市場按應用、技術、給藥途徑、治療領域、容量、最終用戶和地區進行細分。按應用分類，市場分為一次性自動注射器和可重複使用自動注射器。依技術分類，市場分為手動自動注射器和自動自動注射器。依給藥途徑分類，市場分為皮下注射、肌肉注射和靜脈注射。依治療領域分類，市場分為類風濕性關節炎、糖尿病、多發性硬化症、過敏性休克、肥胖症和其他治療領域。依容量分類，市場分為3毫升及以下和3毫升以上。按最終用戶分類，市場分為居家醫療、醫院和診所以及門診護理。依地區分類，市場分為北美、亞太、歐洲、拉丁美洲以及中東和非洲。

全球自動噴油嘴市場促進因素

全球自動注射器市場的主要促進因素之一是需要定期服藥的慢性疾病（例如糖尿病和嚴重過敏症）的日益普遍。鑑於患者依從性和便利性對於治療這些疾病至關重要，自動注射器提供了一個易於使用的解決方案，使患者能夠準確、輕鬆地自我給藥。此外，生物製藥的日益普及（這些藥物通常需要注射治療）進一步推動了對自動注射器的需求。藥物輸送系統的技術進步也促進了這一趨勢，提高了自動注射器產品的整體有效性和吸引力。

全球自動注射器市場的限制因素

全球自動注射器市場的主要限制因素之一是醫療設備領域嚴格的法規環境。監管機構實施嚴格的測試和核准流程，這可能會延遲產品上市並增加製造商的研發成本。此外，遵守各種國際標準也使市場准入和擴張工作變得更加複雜，尤其對於那些旨在跨地區企業發展的公司。這些監管挑戰可能會阻礙中小企業進入市場，並可能扼殺創新。因此，需要有效給藥解決方案的消費者可能難以取得新型自動注射器產品。

全球自動噴油嘴市場趨勢

全球自動注射器市場正呈現出顯著的智慧趨勢，傳統自動注射器也因此具備了數位化連接功能。這些先進的設備使用戶能夠即時查看給藥歷史記錄、接收漏服提醒，並與醫療專業人員就用藥依從性進行無縫溝通。智慧自動注射器的出現正在革新病患管理，提供寶貴的數據洞察，幫助臨床醫師有效調整治療方案。自動注射器市場的數位轉型正在推動藥物輸送系統進入變革階段，旨在提高用藥依從性、最佳化患者療效並促進患者積極參與治療。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太國家
拉丁美洲
- 巴西
- 其他拉丁美洲國家
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲國家

競爭格局

前五大公司對比
主要公司2025年的市場定位
主要市場公司採取的策略
近期市場趨勢
主要公司市佔率（%），2025 年

主要公司簡介

SHL Medical AG
Ypsomed AG
Becton, Dickinson and Company（BD）
EQT IX（Recipharm AB）
West Pharmaceutical Services, Inc.
Molex（Phillips-Medisize）
Halozyme, Inc.
Owen Mumford Ltd.
AbbVie Inc.
Amgen Inc.
Novo Holdings A/S
Johnson & Johnson
Sanofi
GSK PLC
Gerresheimer AG
Medmix（Haselmaier）
SMC Ltd.（Oval Medical Technologies Ltd.）
Kaleo, Inc.
Solteam Incorporation Co., Ltd.
Elcam Drug Delivery Devices
Crossject
Jabil Inc.
Congruence Medical Solutions LLC
Midas Pharma GmbH

簡介目錄

Product Code: SQMIG35A3051

Global Auto Injector Market size was valued at USD 9.58 Billion in 2024 and is poised to grow from USD 10.96 Billion in 2025 to USD 32.2 Billion by 2033, growing at a CAGR of 14.42% in the forecast period (2026-2033).

The Auto Injector Market is experiencing significant growth, driven by various medical, technological, and behavioral factors reshaping drug delivery methods. The increasing prevalence of chronic diseases necessitates regular administration of injectable medications, making autoinjectors an attractive solution for self-administration with limited training, thereby reducing clinic visits and improving treatment adherence. The convenience of autoinjectors is particularly essential for addressing urgent medical situations, such as severe allergic reactions. Innovations in technology have transformed these devices into user-friendly, smart tools featuring automated functions and connectivity for dose tracking. The rise of biologic drugs and heightened patient expectations for home healthcare further propel demand. Additionally, the integration of AI enhances personalization and adherence, allowing for optimized treatment and timely healthcare adjustments.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Auto Injector market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Auto Injector Market Segments Analysis

The Auto Injector Market is segmented into usage, technology, route of administration, therapy area, volume, end user and region. Based on usage, the market is segmented into disposable autoinjectors and reusable autoinjectors. Based on technology, the market is segmented into manual autoinjectors and automatic autoinjectors. Based on route of administration, the market is segmented into subcutaneous, intramuscular and intravenous. Based on therapy area, the market is segmented into rheumatoid arthritis, diabetes, multiple sclerosis, anaphylaxis, obesity and other therapy areas. Based on volume, the market is segmented into up to 3ml and above 3ml. Based on end user, the market is segmented into home care settings, hospitals & clinics and ambulatory care settings. Based on region, the market is segmented into North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa.

Driver of the Global Auto Injector Market

One of the key market drivers for the global auto injector market is the increasing prevalence of chronic diseases that require regular medication administration, such as diabetes and severe allergies. As patient compliance and convenience become paramount in the treatment of these conditions, auto injectors provide a user-friendly solution that allows patients to self-administer medication with precision and ease. Additionally, the rising adoption of biologics, which often necessitate injectable forms of therapy, further fuels demand for auto injectors. This trend is complemented by technological advancements in drug delivery systems, enhancing the overall effectiveness and appeal of auto injector products.

Restraints in the Global Auto Injector Market

One key market restraint for the global auto injector market is the stringent regulatory environment surrounding medical devices. Regulatory bodies impose rigorous testing and approval processes that can delay product launches and increase development costs for manufacturers. Additionally, compliance with varying international standards can complicate market entry and expansion efforts, particularly for companies seeking to operate in multiple regions. These regulatory challenges may deter smaller companies from entering the market and can hinder innovation, ultimately limiting the availability of new auto injector products to consumers in need of effective administration solutions for their medications.

Market Trends of the Global Auto Injector Market

The Global Auto Injector market is witnessing a significant trend towards the integration of smart technologies, enhancing traditional autoinjectors with digital connectivity features. These advanced devices enable users to monitor their dosage history in real-time, receive reminders for missed doses, and facilitate communication with healthcare professionals regarding adherence. This shift towards smart autoinjectors is revolutionizing patient management by offering valuable data insights that empower clinicians to tailor treatment plans effectively. This digital evolution in the auto injector market aims to improve medication adherence, optimize patient outcomes, and promote proactive healthcare engagement, marking a transformative phase in drug delivery systems.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factor
Degree of Competition
Top Investment Pockets
Ecosystem of the Market
Value Chain Analysis
Supply Chain Analysis
Technology Analysis
Patent Analysis
Pricing Analysis
Trade Analysis
Customer & Buying Criteria Analysis
Regulatory landscape

Auto injector Market, By Usage

Market Overview
Disposable Autoinjectors
Reusable Autoinjectors

Auto injector Market, By Technology

Market Overview
Manual Autoinjectors
Automatic Autoinjectors

Auto injector Market, By Route Of Administration

Market Overview
Subcutaneous
Intramuscular
Intravenous

Auto injector Market, By Therapy Area

Market Overview
Rheumatoid Arthritis
Diabetes
Multiple Sclerosis
Anaphylaxis
Obesity
Other Therapy Areas

Auto injector Market, By Volume

Market Overview
Up To 3ml
Above 3ml

Auto injector Market, By End User

Market Overview
Home Care Settings
Hospitals & Clinics
Ambulatory Care Settings

Auto injector Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

SHL Medical AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ypsomed AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
EQT IX (Recipharm AB)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
West Pharmaceutical Services, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Molex (Phillips-Medisize)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Halozyme, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Owen Mumford Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AbbVie Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Novo Holdings A/S
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GSK PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Gerresheimer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medmix (Haselmaier)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SMC Ltd. (Oval Medical Technologies Ltd.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kaleo, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Solteam Incorporation Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elcam Drug Delivery Devices
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Crossject
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jabil Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Congruence Medical Solutions LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Midas Pharma GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments